aid: accent-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/accent-therapeutics.png
name: Accent Therapeutics
description: 'Accent Therapeutics is a clinical-stage biopharmaceutical company pioneering a new class
  of small-molecule precision cancer therapies that target critical intracellular dependencies spanning
  multiple types of cancer. Its pipeline is led by ATX-295, a novel KIF18A inhibitor in clinical
  development, with data presented at AACR and ASCO. Backed by GV, Accent focuses on precision oncology
  drug discovery and development. The company does not currently publish a public developer API; this
  profile captures its corporate and web identity in the API Evangelist network.'
url: https://raw.githubusercontent.com/api-evangelist/accent-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Life Sciences
- Biotechnology
- Pharmaceuticals
- Oncology
- Precision Medicine
- Drug Discovery
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/accent-therapeutics-domain-security.yml
- type: Website
  url: https://accenttx.com
- type: Blog
  url: https://accenttx.com/news-events/
- type: PrivacyPolicy
  url: https://accenttx.com/privacy-policy/
- type: TermsOfService
  url: https://accenttx.com/terms-of-use/
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence